News >

Liquid Biopsies Reliably and Quickly Detect Genomic Biomarkers in Metastatic NSCLC

Kristi Rosa
Published: Tuesday, Apr 16, 2019

Vassiliki A. Papadimitrakopoulou, MD

Vassiliki A.

Papadimitrakopoulou, MD
Liquid biopsies can reliably detect guideline-recommended biomarkers in patients with stage IV non–small cell lung cancer (NSCLC), said Vassiliki A. Papadimitrakopoulou, MD, with a quicker turnaround time compared with that of standard tissue-based assays.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication